Jess Kerr-Gaffney

Ms. Jess Kerr-Gaffney

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Journal of Psychosomatic Research
Verified
Journal Article
Open access
HWHeather Westwood
Heather Westwood
JKJess Kerr-Gaffney
Jess Kerr-Gaffney
DSDaniel Richard Stahl
Daniel Richard Stahl
KTKate Tchanturia
Kate Tchanturia
The aim of this review was to synthesise the literature on the use of the Toronto Alexithymia Scale (TAS) in eating disorder populations and Healthy Controls (HCs) and to compare TAS scores in these groups. Electronic databases were searched systematically for studies using the TAS and meta-analyses were performed to statistically compare scores on the TAS between individuals with eating disorders and HCs. Forty-eight studies using the TAS with both a clinical eating disorder group and HCs were identified. Of these, 44 were included in the meta-analyses, separated into: Anorexia Nervosa; Anorexia Nervosa, Restricting subtype; Anorexia Nervosa, Binge-Purge subtype, Bulimia Nervosa and Binge Eating Disorder. For all groups, there were significant differences with medium or large effect sizes between the clinical group and HCs, with the clinical group scoring significantly higher on the TAS, indicating greater difficulty with identifying and labelling emotions. Across the spectrum of eating disorders, individuals report having difficulties recognising or describing their emotions. Given the self-report design of the TAS, research to develop and evaluate treatments and clinician-administered assessments of alexithymia is warranted.

10 April 2018 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
JKJess Kerr-Gaffney
Jess Kerr-Gaffney
AHAmy Harrison
Amy Harrison
KTKate Tchanturia
Kate Tchanturia
Social anxiety disorder is one of the most common comorbid conditions in eating disorders (EDs). The aim of the current review and meta-analysis is to provide a qualitative summary of what is known about social anxiety (SA) in EDs, as well as to compare levels of SA in those with EDs and healthy controls. Electronic databases were systematically searched for studies using self-report measures of SA in ED populations. In total, 38 studies were identified, 12 of which were included in the meta-analyses. For both anorexia nervosa (AN) and bulimia nervosa, there were significant differences between ED groups and HCs, with medium to large effect sizes. Findings from the qualitative review indicate that levels of SA are similar across the ED diagnoses, and SA improves with treatment in AN. In addition, high levels of SA are associated with more severe ED psychopathology, but not body mass index. These findings add to the wider literature on socio-emotional functioning in EDs, and may have implications for treatment strategies.

23 December 2018 in International Journal of Eating Disorders
Verified
Journal Article
Closed access
PDF file
JKJess Kerr-Gaffney
Jess Kerr-Gaffney
AHAmy Harrison
Amy Harrison
KTKate Tchanturia
Kate Tchanturia

17 April 2023 in BJPsych Open
Verified
Journal Article
Open access
PDF file
DDDaniel M. Dietch
Daniel M. Dietch
JKJess Kerr-Gaffney
Jess Kerr-Gaffney
MHMeghan Hockey
Meghan Hockey
WMWolfgang Marx
Wolfgang Marx
ARAnu Ruusunen
Anu Ruusunen
VMValeria Mondelli
Valeria Mondelli
Background: There is mounting interest in the potential efficacy of low carbohydrate and very low carbohydrate ketogenic diets in various neurological and psychiatric disorders.Aims: To conduct a systematic review and narrative synthesis of low carbohydrate and ketogenic diets (LC/KD) in adults with mood and anxiety disorders.Method: MEDLINE, Embase, PsycINFO and Cochrane databases were systematically searched for articles from inception to 6 September 2022. Studies that included adults with any mood or anxiety disorder treated with a low carbohydrate or ketogenic intervention, reporting effects on mood or anxiety symptoms were eligible for inclusion. PROSPERO registration CRD42019116367.Results: The search yielded 1377 articles, of which 48 were assessed for full-text eligibility. Twelve heterogeneous studies (stated as ketogenic interventions, albeit with incomplete carbohydrate reporting and measurements of ketosis; diet duration: 2 weeks to 3 years;n= 389; age range 19 to 75 years) were included in the final analysis. This included nine case reports, two cohort studies and one observational study. Data quality was variable, with no high-quality evidence identified. Efficacy, adverse effects and discontinuation rates were not systematically reported. There was some evidence for efficacy of ketogenic diets in those with bipolar disorder, schizoaffective disorder and possibly unipolar depression/anxiety. Relapse after discontinuation of the diet was reported in some individuals.Conclusions: Although there is no high-quality evidence of LC/KD efficacy in mood or anxiety disorders, several uncontrolled studies suggest possible beneficial effects. Robust studies are now needed to demonstrate efficacy, to identify clinical groups who may benefit and whether a ketogenic diet (beyond low carbohydrate) is required and to characterise adverse effects and the risk of relapse after diet discontinuation.

6 January 2025 in International Journal of Eating Disorders
Verified
Journal Article
Open access
MSMichelle Sader
Michelle Sader
AWAnnabel Weston
Annabel Weston
KBKyle Buchan
Kyle Buchan
JKJess Kerr-Gaffney
Jess Kerr-Gaffney
KGKarri Gillespie‐Smith
Karri Gillespie‐Smith
FDFiona Duffy
Fiona Duffy
Objective: Avoidant/restrictive food intake disorder (ARFID) is a feeding and eating disorder characterized by extensive avoidance and/or restriction of food. Existing research demonstrates that ARFID is over‐represented in Autistic populations and vice‐versa, with both groups exhibiting shared characteristics. This meta‐analysis investigated the co‐occurrence between ARFID and autism via determination of autism prevalence in ARFID populations, and ARFID prevalence in Autistic groups.Method: This review systematically identified literature evaluating those with ARFID and Autistic individuals. Literature was searched for using SCOPUS, MEDLINE, and Web of Science. Selected publications included Autistic individuals and those with ARFID who either received a formal diagnosis of autism and/or ARFID or met clinical threshold cut‐off scores on validated autism and/or ARFID questionnaires. Prevalence was reported in proportion‐based values alongside 95% confidence intervals (CIs).Results: This meta‐analysis identified 21 studies (kARFID = 18 papers; kAutism = 3 papers) comprising of n = 7442 participants (nARFID = 1708; nAutism = 5734). Prevalence of autism diagnoses was 16.27% in those with ARFID (95% CI = 8.64%–28.53%), and ARFID prevalence in Autistic groups was 11.41% (95% CI = 2.89%–35.76%). Gender and ethnicity served as significant sources of heterogeneity in ARFID papers. There was insufficient data to provide comparator values or prevalence across study population and distinct underpinning drivers of ARFID.Discussion: Meta‐analytic findings highlight significant rates of co‐occurrence between autism and ARFID, suggesting that in clinical settings, it may be beneficial to consider screening Autistic individuals for ARFID and vice‐versa. Future research should further investigate co‐occurrence across ARFID profiles, gender, and ethnicity.

5 October 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
RSRachel Primo Santana
Rachel Primo Santana
JKJess Kerr-Gaffney
Jess Kerr-Gaffney
AAAnda Ancane
Anda Ancane
Allan YoungAllan Young
Allan Young
Impulsive behaviour is a key characteristic of mania in bipolar disorder (BD). However, there is mixed evidence as to whether impulsivity is a trait feature of the disorder, present in the euthymic state in the absence of mania. The aim of this systematic review and meta-analysis was to examine whether impulsivity is elevated in euthymic BD in comparison to controls. Electronic databases were searched for papers published until April 2022 reporting data on a self-report or behavioural measure of impulsivity in a euthymic BD group and a healthy control group. In total, 46 studies were identified. Euthymic BD showed significantly higher levels of self-reported impulsivity compared to controls (large effect size). Euthymic BD also showed significantly higher levels of impulsivity on response inhibition and inattention tasks, with moderate and large effect sizes, respectively. Only two studies measured delay of gratification, finding no significant differences between groups. Our results suggest impulsivity may be a trait feature of BD, however longitudinal cohort studies are required to confirm whether elevated impulsivity is present before illness onset. Future research should establish whether cognitive interventions are beneficial in improving impulsivity in BD.